Request Demo
Last update 24 May 2025
YY-201 (Shanghai Yuyao)
Last update 24 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms YY 201, YY-201, YY201 |
Target |
Action inhibitors |
Mechanism STAT3 inhibitors(Signal transducer and activator of transcription 3 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with YY-201 (Shanghai Yuyao)NCT06225856
An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies
100 Clinical Results associated with YY-201 (Shanghai Yuyao)
Login to view more data
100 Translational Medicine associated with YY-201 (Shanghai Yuyao)
Login to view more data
100 Patents (Medical) associated with YY-201 (Shanghai Yuyao)
Login to view more data
100 Deals associated with YY-201 (Shanghai Yuyao)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Promyelocytic Leukemia | Phase 1 | China | 26 Oct 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 26 Oct 2023 | |
| Chronic phase chronic myeloid leukemia | Phase 1 | China | 26 Oct 2023 | |
| Large Granular Lymphocytic Leukemia | Phase 1 | China | 26 Oct 2023 | |
| Peripheral T-Cell Lymphoma | Phase 1 | China | 26 Oct 2023 | |
| Primary Malignant Liver Neoplasm | Phase 1 | China | 26 Oct 2023 | |
| Refractory acute myeloid leukemia | Phase 1 | China | 26 Oct 2023 | |
| Squamous Cell Carcinoma of Head and Neck | Phase 1 | China | 26 Oct 2023 | |
| Triple Negative Breast Cancer | Phase 1 | China | 26 Oct 2023 | |
| Pancreatic Cancer | Phase 1 | China | 26 Oct 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free